Metabolomics identifies perturbations in amino acid metabolism in the prefrontal cortex of the learned helplessness rat model of depression

Major depressive disorder is a serious psychiatric condition associated with high rates of suicide and is a leading cause of health burden worldwide. However, the underlying molecular mechanisms of major depression are still essentially unclear. In our study, a non-targeted gas chromatography-mass spectrometry-based metabolomics approach was used to investigate metabolic changes in the prefrontal cortex of the learned helplessness (LH) rat model of depression. Body-weight measurements and behavioral tests including the active escape test, sucrose preference test, forced swimming test, elevated plus-maze and open field test were used to assess changes in the behavioral spectrum after inescapable footshock stress. Rats in the stress group exhibited significant learned helpless and depression-like behaviors, while without any significant change in anxiety-like behaviors. Using multivariate and univariate statistical analysis, a total of 18 differential metabolites were identified after the footshock stress protocol. Ingenuity Pathways Analysis and MetaboAnalyst were applied for predicted pathways and biological functions analysis. "Amino Acid Metabolism, Molecule Transport, Small Molecule Biochemistry" was the most significantly altered network in the LH model. Amino acid metabolism, particularly glutamate metabolism, cysteine and methionine metabolism, arginine and proline metabolism, was significantly perturbed in the prefrontal cortex of LH rats.

[1]  P. Renshaw,et al.  Chronic Creatine Supplementation Alters Depression-like Behavior in Rodents in a Sex-Dependent Manner , 2010, Neuropsychopharmacology.

[2]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[3]  Peng Xie,et al.  Plasma metabonomics as a novel diagnostic approach for major depressive disorder. , 2012, Journal of proteome research.

[4]  Ellen Frank,et al.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives , 2012, The Lancet.

[5]  J. Neumaier,et al.  Congenitally learned helpless rats show abnormalities in intracellular signaling , 2003, Biological Psychiatry.

[6]  F. Petty,et al.  Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain. , 1999, Journal of psychiatric research.

[7]  M. Dickman,et al.  Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. , 2008, Free radical biology & medicine.

[8]  Christophe D. Proulx,et al.  Synaptic potentiation onto habenula neurons in learned helplessness model of depression , 2010, Nature.

[9]  G. Freedman,et al.  Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 , 2013, PLoS medicine.

[10]  P. Eastmond,et al.  Trehalose metabolism: a regulatory role for trehalose-6-phosphate? , 2003, Current opinion in plant biology.

[11]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[12]  S. Loureiro,et al.  Cytoskeleton of cortical astrocytes as a target to proline through oxidative stress mechanisms. , 2013, Experimental cell research.

[13]  G. Baker,et al.  An update on the role of glutamate in the pathophysiology of depression , 2010, Acta psychiatrica Scandinavica.

[14]  A. Terry,et al.  Cysteamine Attenuates the Decreases in TrkB Protein Levels and the Anxiety/Depression-Like Behaviors in Mice Induced by Corticosterone Treatment , 2011, PloS one.

[15]  G. Gebhart,et al.  Special Report: The 1996 Guide for the Care and Use of Laboratory Animals. , 1997, ILAR journal.

[16]  G. Martinotti,et al.  A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. , 2016, CNS & neurological disorders drug targets.

[17]  G. Rajkowska,et al.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. , 2013, Current drug targets.

[18]  M. Stipanuk,et al.  Dealing with methionine/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur , 2011, Journal of Inherited Metabolic Disease.

[19]  C. Hanstock,et al.  Decreased Prefrontal Myo-Inositol in Major Depressive Disorder , 2005, Biological Psychiatry.

[20]  Maurizio Fava,et al.  The STAR*D project results: A comprehensive review of findings , 2007, Current psychiatry reports.

[21]  E. Seifritz,et al.  Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression. , 2011, Pharmacology & therapeutics.

[22]  D. Becker,et al.  Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death. , 2012, Free radical biology & medicine.

[23]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[24]  P. Gass,et al.  Synaptoproteomics of learned helpless rats involve energy metabolism and cellular remodeling pathways in depressive-like behavior and antidepressant response , 2011, Neuropharmacology.

[25]  Allan Collins,et al.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies , 1997, Psychopharmacology.

[26]  P. Xie,et al.  A novel urinary metabolite signature for diagnosing major depressive disorder. , 2013, Journal of proteome research.

[27]  C. Shively,et al.  Macaques Exhibit a Naturally-Occurring Depression Similar to Humans , 2015, Scientific Reports.

[28]  G. Rajkowska,et al.  Gliogenesis and glial pathology in depression. , 2007, CNS & neurological disorders drug targets.

[29]  A. Schousboe,et al.  The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.

[30]  Y. Ho,et al.  Adult neurogenesis is reduced in the dorsal hippocampus of rats displaying learned helplessness behavior , 2010, Neuroscience.

[31]  P. Xie,et al.  Amino acid metabolic dysfunction revealed in the prefrontal cortex of a rat model of depression , 2015, Behavioural Brain Research.

[32]  Stephen E. Stein,et al.  Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.

[33]  Chris Tachibana.  What's next in 'omics: The metabolome , 2014 .

[34]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[35]  B. McEwen.  Allostasis and Allostatic Load: Implications for Neuropsychopharmacology , 2000, Neuropsychopharmacology.

[36]  P. Xie,et al.  The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression , 2016, Behavioural Brain Research.

[37]  P. Gebicke-haerter,et al.  Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression , 2010, Neuropharmacology.

[38]  Alexander Erban,et al.  TagFinder for the quantitative analysis of gas chromatography - mass spectrometry (GC-MS)-based metabolite profiling experiments , 2008, Bioinform..

[39]  K. Hashimoto,et al.  Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness , 2013, Psychopharmacology.

[40]  J. Ayuso-Mateos,et al.  Depressive disorders and suicide: Epidemiology, risk factors, and burden , 2013, Neuroscience & Biobehavioral Reviews.

[41]  C. Conrad,et al.  Sex differences and phase of light cycle modify chronic stress effects on anxiety and depressive-like behavior , 2011, Behavioural Brain Research.

[42]  S. Mishra,et al.  Neurodegenerative evidences during early onset of depression in CMS rats as detected by proton magnetic resonance spectroscopy at 7T , 2012, Behavioural Brain Research.

[43]  D. Souza,et al.  Effects of Depressive-Like Behavior of Rats on Brain Glutamate Uptake , 2010, Neurochemical Research.

[44]  Peng Xie,et al.  Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder* , 2012, Molecular & Cellular Proteomics.

[45]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[46]  Peng Xie,et al.  Metabolomic identification of molecular changes associated with stress resilience in the chronic mild stress rat model of depression , 2013, Metabolomics.

[47]  M. Fava,et al.  S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: efficacy and effects of histamine and carnitine as moderators of response. , 2014, Journal of affective disorders.

[48]  P. Xie,et al.  Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression. , 2014, Molecular bioSystems.

[49]  Y. Osher,et al.  Creatine monohydrate in resistant depression: a preliminary study. , 2007, Bipolar disorders.

[50]  Peng Xie,et al.  Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. , 2015, Journal of proteome research.

[51]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..